Grufity logoGrufity logo
ScreenerStocksFundsSectorsWatchlists
DVA

DaVita Inc

DVA

105.73USD+1.57 (+1.51%)Market Closed
Watchlist

Market Summary

USD105.73+1.57
Market Closed
1.51%

DVA Alerts

  • Big jump in Earnings (Y/Y)

DVA Stock Price

View Fullscreen

DVA RSI Chart

DVA Valuation

Market Cap

9.7B

Price/Earnings (Trailing)

15.86

Price/Sales (Trailing)

0.81

EV/EBITDA

9.78

Price/Free Cashflow

7.35

DVA Price/Sales (Trailing)

DVA Profitability

EBT Margin

7.36%

Return on Equity

45.97%

Return on Assets

2.76%

Free Cashflow Yield

13.61%

DVA Fundamentals

DVA Revenue

Revenue (TTM)

11.9B

Revenue Y/Y

5.85%

Revenue Q/Q

4.03%

DVA Earnings

Earnings (TTM)

609.0M

Earnings Y/Y

134.07%

Earnings Q/Q

38.02%

Price Action

Last 7 days

4.2%

Last 30 days

32.0%

Last 90 days

10.7%

Trailing 12 Months

41.3%

How does DVA drawdown profile look like?

DVA Financial Health

Current Ratio

1.25

Debt/Equity

8.45

Debt/Cashflow

0.23

DVA Investor Care

Shares Dilution (1Y)

1.38%

Diluted EPS (TTM)

6.58

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs
Net sales
YearQ1Q2Q3Q4
202311.7B11.7B11.9B0
202211.6B11.6B11.6B11.6B
202111.5B11.6B11.6B11.6B
202011.5B11.5B11.5B11.6B
201911.3B11.3B11.3B11.4B
201811.1B11.3B11.4B11.4B
201710.7B10.8B10.8B10.9B
201610.2B10.3B10.5B10.7B
201513.0B13.3B13.6B10.0B
201412.0B12.3B12.5B12.8B
20139.2B10.1B11.2B11.8B
20127.1B7.4B7.6B8.2B
20116.4B6.5B6.6B6.8B
20106.2B6.3B6.4B6.4B
20095.8B5.9B6.0B6.1B
20085.4B5.5B5.6B5.7B
20070005.3B

Latest Insider Trading transactions for DVA

Filter Transactions
Datesorted ascendingNameBuy/Sell$ ValueAvg. Price# SharesTitle
Nov 15, 2023
nehra john m
acquired
-
-
529
-
Nov 15, 2023
desoer barbara j
acquired
-
-
529
-
Nov 15, 2023
berg charles
acquired
-
-
529
-
Nov 15, 2023
moore gregory j.
acquired
-
-
529
-
Nov 15, 2023
berry christopher michael
acquired
-
-
8,468
chief accounting officer
Nov 15, 2023
schechter adam h
acquired
-
-
529
-
Nov 15, 2023
hollar jason m.
acquired
-
-
529
-
Nov 15, 2023
yale phyllis r
acquired
-
-
529
-
Nov 15, 2023
schoppert wendy lee
acquired
-
-
454
-
Nov 15, 2023
arway pamela m
acquired
-
-
529
-

1–10 of 50

Which funds bought or sold DVA recently?

View All Details
Datesorted ascendingFund NameType% Chg$ Change$ Held% Portfolio
Dec 06, 2023
Raleigh Capital Management Inc.
new
-
10,020
10,020
-%
Dec 06, 2023
VisionPoint Advisory Group, LLC
unchanged
-
-207
3,309
-%
Dec 06, 2023
CITIGROUP INC
reduced
-14.36
-1,398,750
5,804,140
-%
Dec 01, 2023
B. Riley Wealth Advisors, Inc.
added
9.85
7,088
218,175
0.01%
Nov 30, 2023
Neo Ivy Capital Management
added
148
353,000
617,000
0.27%
Nov 27, 2023
BANQUE PICTET & CIE SA
sold off
-100
-2,163,220
-
-%
Nov 24, 2023
DEUTSCHE BANK AG\
added
25.2
3,753,820
24,841,100
0.02%
Nov 22, 2023
Graham Capital Management, L.P.
reduced
-37.00
-579,010
842,640
0.02%
Nov 22, 2023
Public Sector Pension Investment Board
added
12.38
30,060
554,513
-%
Nov 22, 2023
KBC Group NV
unchanged
-
-
4,804,000
0.02%

1–10 of 39

Latest Funds Activity

Are funds buying DVA calls or puts?
Calls
Puts
No. of funds holding Calls - Puts
Net Call Options
No. of funds that own DVA
No. of Funds

Schedule 13G FIlings of DaVita Inc

Date FiledName of FilerPercent of ClassNo. of SharesForm Type
Feb 09, 2023
vanguard group inc
6.84%
6,166,112
SC 13G/A
Feb 01, 2023
blackrock inc.
5.4%
4,822,086
SC 13G/A
Feb 14, 2022
berkshire hathaway inc
37.5%
36,095,570
SC 13D/A
Feb 09, 2022
vanguard group inc
7.34%
7,481,018
SC 13G/A
Feb 01, 2022
blackrock inc.
5.5%
5,654,952
SC 13G/A
Aug 04, 2021
berkshire hathaway inc
34.4%
36,095,570
SC 13D/A
Feb 16, 2021
berkshire hathaway inc
33.0%
36,095,570
SC 13D/A
Feb 10, 2021
vanguard group inc
7.69%
8,611,932
SC 13G/A
Jan 29, 2021
blackrock inc.
5.3%
5,939,662
SC 13G/A
Sep 21, 2020
berkshire hathaway inc
31.7%
36,095,570
SC 13D/A

Recent SEC filings of DaVita Inc

View All Filings
Date Filed Form Type Document
Nov 17, 2023
4
Insider Trading
Nov 17, 2023
4
Insider Trading
Nov 17, 2023
4
Insider Trading
Nov 17, 2023
4
Insider Trading
Nov 17, 2023
4
Insider Trading
Nov 17, 2023
4
Insider Trading
Nov 17, 2023
4
Insider Trading
Nov 17, 2023
4
Insider Trading
Nov 17, 2023
4
Insider Trading
Nov 17, 2023
4
Insider Trading

DVA Fair Value

Loading...

Peers (Alternatives to DaVita Inc)

View All Peers In Detail
NameMkt Capsorted ascendingRevenuePrice %, 1MReturns, 1YP/EP/SRev 1-YrInc 1-Yr
LARGE-CAP
507.1B
360.0B
1.94% 1.34%
23.38
1.41
14.24% 11.62%
95.3B
347.8B
5.35% -27.64%
10.94
0.27
10.34% 159.11%
91.1B
189.9B
-12.60% -22.05%
13.64
1.92
5.24% 22.27%
68.3B
63.2B
8.96% 6.67%
11.95
1.08
5.62% 6.32%
39.7B
150.1B
3.44% -15.03%
16.23
0.26
6.04% 21.35%
MID-CAP
9.7B
11.9B
32.01% 41.29%
15.86
0.81
2.36% -10.41%
9.4B
14.0B
3.25% 4.87%
13.92
0.67
6.03% -8.61%
8.6B
2.2B
-1.50% 10.15%
35.21
3.87
4.50% -6.69%
6.6B
2.9B
-3.11% -12.16%
-359.29
2.29
13.16% -106.47%
2.6B
4.1B
9.38% -42.09%
9.26
0.63
-25.26% -41.25%
SMALL-CAP
1.6B
1.3B
13.24% 13.97%
34.75
1.17
27.06% -27.04%
1.4B
1.0B
6.69% -15.76%
25.11
1.41
10.84% 30.19%
982.6M
3.0B
18.37% 74.00%
-7.96
0.33
6.98% 58.07%
36.3M
-
2.22% -73.51%
-2.51
-
- -27.68%
15.3M
20.7M
7.02% -13.27%
52.66
0.74
6.53% -78.75%

DaVita Inc News

Latest updates
Nasdaq07 Dec 202304:36 pm17 hours ago
DirectorsTalk Interviews07 Dec 202303:37 pm18 hours ago
Nasdaq07 Dec 202303:20 pm19 hours ago
Nasdaq07 Dec 202302:48 pm19 hours ago
Nasdaq07 Dec 202301:22 pm21 hours ago
Nasdaq06 Dec 202303:22 pm43 hours ago
Nasdaq06 Dec 202302:24 pm44 hours ago
Nasdaq06 Dec 202312:34 pm45 hours ago
Nasdaq05 Dec 202304:59 pm2 days ago
Nasdaq05 Dec 202310:22 am3 days ago
InvestorsObserver04 Dec 202308:15 pm3 days ago
Nasdaq04 Dec 202305:09 pm3 days ago
Forbes04 Dec 202302:33 pm3 days ago
Nasdaq04 Dec 202312:47 pm3 days ago
Nasdaq04 Dec 202312:27 pm3 days ago

Financials for DaVita Inc

Income Statement (Last 12 Months)
(In Millions)
Income Statement (Quarterly)
(In Millions)
(*) denotes actual numbers (not divided by Millions)
Description(%) Q/Q2023Q32023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q12018Q42018Q3
Revenue4.0%3,1213,0002,8732,9172,9492,9272,8182,9442,9382,9172,8202,9052,9242,8802,8412,8992,9042,8432,7432,8212,847
Costs and Expenses1.2%2,6252,5952,5612,6612,6372,4942,4792,5552,4632,4262,3772,5242,4862,4702,3762,4362,5262,3812,4032,4332,558
  S&GA Expenses3.5%377364332380365315295323293298281305363316264278299275251269336
EBITDA Margin-100.0%-0.14*0.14*0.15*0.16*0.17*0.20*0.21*--0.19*0.19*0.21*0.21*0.21*0.20*0.19*0.18*---
Income Taxes41.0%69.0049.0044.0034.0043.0064.0057.0066.0075.0081.0085.0073.0066.0083.0092.0082.0065.0076.0057.0052.0052.00
Earnings Before Taxes28.1%378295215147207349263315394432377327283338369382274324216259167
EBT Margin-100.0%-0.07*0.08*0.08*0.10*0.11*0.12*0.13*0.13*0.12*0.11*0.11*0.12*0.12*0.12*0.10*-----
Net Income38.0%24717911668.00105225162187260294237174159202240245143274149-149-136
Net Income Margin-100.0%-0.04*0.04*0.05*0.06*0.07*0.08*0.08*0.08*0.07*0.07*0.07*0.07*0.07*0.08*0.07*-----
Free Cashflow-100.0%-32631515056746.001993404095309.00260324514205461-----
Balance Sheet
(In Millions)
Balance Sheet
(In Millions)
Description(%) Q/Q2023Q32023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q12018Q42018Q3
Assets-0.2%16,92916,95916,72816,92816,96217,10117,08717,12117,63417,81017,64716,98917,04719,30517,59617,31117,45219,93122,60619,11019,358
  Current Assets4.4%3,1353,0023,0403,1553,2023,2643,1293,1683,8403,9793,8673,1493,4305,7804,0243,6903,9996,3919,2258,4248,930
    Cash Equivalents66.5%5453273172443683564215551,1391,2061,0615028173,0361,4881,2091,3573,682561415540
  Inventory-0.6%11011010710910711010810711411511611210698.0096.0098.0099.0097.0010410791.00
  Net PPE-1.9%3,0973,1583,2163,2563,2403,3053,4393,4803,4633,4863,4903,5223,4183,4183,4453,4733,4193,4053,3923,3943,276
  Goodwill-0.3%7,0887,1067,0907,0777,0237,0207,0737,0466,9416,9446,8916,9196,8686,7916,7786,7886,7666,8656,7996,8426,703
Liabilities-1.6%14,10414,32914,30914,70314,88914,94014,67814,75114,88214,92114,86514,09213,98915,72914,23513,81213,64314,50217,37614,07714,264
  Current Liabilities5.6%2,5382,4032,5652,6202,5372,3112,4202,3992,3632,3862,3152,4762,4994,2752,2212,3722,2075,7078,2314,8914,855
  Long Term Debt-3.6%8,2858,5988,4188,6938,8679,0658,6878,7298,7718,7988,8307,9177,8677,8958,4427,9788,0145,3785,7878,1738,441
Shareholder's Equity17.9%1,1991,0178257125336058447561,1491,2781,2481,3841,5752,1541,9482,1332,3194,0493,8753,7033,825
  Retained Earnings52.6%7154692901748477415163541,6441,3841,0908532,0321,8731,6711,4323,3493,2062,9322,7433,951
  Additional Paid-In Capital-0.5%5535565906076095785955405255236035976947197207499079899909951,056
Shares Outstanding0.1%91.0091.0091.0090.0090.0094.0096.0097.00105106109110121122125126151166166166167
Minority Interest-4.5%180189194164169170175181179185185183179180185186194194211205205
Cashflow (Last 12 Months)
(In Millions)
Cashflow (Quarterly)
(In Millions)
(*) denotes actual numbers (not divided by Millions)
Description(%) Q/Q2023Q32023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q12018Q42018Q3
Cashflow From Operations46.9%661450463344711188322530567680154485483651360681641610141389458
  Share Based Compensation-9.1%27.0030.0025.0018.0028.0025.0025.0026.0024.0028.0024.0024.0025.0022.0020.0020.0019.0017.0012.0013.0040.00
Cashflow From Investing59.7%-139-347-116-213-153-144-118-336-164-159-124-338-80.17-244-162-138-2683,603-200-344-237
Cashflow From Financing-307.4%-394-96.84-275-230-445-103-341-774-464-381537-465-2,6211,14397.00-692-2,693-1,635325-202-117
  Buy Backs-----185381236656322244316433704-3225471,76473.00--356

DVA Income Statement

2023-09-30
CONSOLIDATED STATEMENTS OF INCOME (unaudited) - USD ($)
$ in Thousands
3 Months Ended9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Income Statement [Abstract]    
Dialysis patient service revenues$ 2,951,950$ 2,846,494$ 8,602,669$ 8,372,874
Other revenues169,382102,200391,731320,132
Total revenues3,121,3322,948,6948,994,4008,693,006
Operating expenses:    
Patient care costs2,067,3152,085,5556,181,3486,120,872
General and administrative376,883365,4471,072,513975,486
Depreciation and amortization188,423194,414550,166538,534
Equity investment income, net(7,228)(8,509)(22,502)(24,696)
Total operating expenses2,625,3932,636,9077,781,5257,610,196
Operating income495,939311,7871,212,8751,082,810
Debt expense(98,080)(99,680)(302,361)(256,057)
Debt Extinguishment And Modification Costs007,9620
Other loss, net(19,650)(4,898)(14,525)(7,968)
Income before income taxes378,209207,209888,027818,785
Income tax expense68,84842,515161,621163,757
Net income309,361164,694726,406655,028
Less: Net income attributable to noncontrolling interests(62,729)(59,328)(185,536)(162,731)
Net income attributable to DaVita Inc.$ 246,632$ 105,366$ 540,870$ 492,297
Earnings per share attributable to DaVita Inc.:    
Basic net income$ 2.70$ 1.16$ 5.95$ 5.24
Diluted net income$ 2.62$ 1.13$ 5.80$ 5.07
Weighted average shares for earnings per share:    
Basic shares91,322,00091,160,00090,937,00093,959,000
Diluted shares94,041,00093,263,00093,317,00097,153,000

DVA Balance Sheet

2023-09-30
CONSOLIDATED BALANCE SHEETS (unaudited) - USD ($)
$ in Thousands
Sep. 30, 2023
Dec. 31, 2022
ASSETS  
Cash and Cash Equivalents, at Carrying Value$ 449,458$ 244,086
Restricted Cash and Cash Equivalents95,66794,903
Short-term investments11,71377,693
Accounts receivable, net2,024,8272,132,070
Inventories109,620109,122
Other receivables352,965413,976
Prepaid and other current assets91,10978,839
Income tax receivable04,603
Total current assets3,135,3593,155,292
Property and equipment, net3,097,4833,256,397
Operating lease right-of-use assets2,509,4162,666,242
Intangible assets, net185,403182,687
Equity method and other investments565,394231,108
Long-term investments45,32044,329
Other long-term assets302,142315,587
Goodwill7,088,2237,076,610
Total assets16,928,74016,928,252
LIABILITIES AND EQUITY  
Accounts payable435,417479,780
Other liabilities808,000802,469
Accrued compensation and benefits770,184692,654
Current portion of operating lease liabilities393,440395,401
Current portion of long-term debt108,558231,404
Income tax payable22,33118,039
Total current liabilities2,537,9302,619,747
Long-term operating lease liabilities2,342,1702,503,068
Long-term debt8,285,1468,692,617
Other long-term liabilities184,944105,233
Deferred income taxes753,871782,787
Total liabilities14,104,06114,703,452
Commitments and contingencies:  
Noncontrolling interests subject to put provisions1,445,4031,348,908
Equity:  
Preferred Stock, Value, Issued00
Common Stock, Value, Issued9190
Additional paid-in capital552,651606,935
Retained earnings715,357174,487
Accumulated other comprehensive loss(68,898)(69,186)
Total DaVita Inc. shareholders' equity1,199,201712,326
Noncontrolling interests not subject to put provisions180,075163,566
Total equity1,379,276875,892
Total liabilities and equity$ 16,928,740$ 16,928,252
DVA
DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers. In addition, the company offers integrated care and disease management services to patients in risk-based and other integrated care arrangements; clinical research programs; physician services; and comprehensive kidney care services. Further, it engages in the provision of acute inpatient dialysis services and related laboratory services; and transplant software business. The company was formerly known as DaVita HealthCare Partners Inc. and changed its name to DaVita Inc. in September 2016. DaVita Inc. was incorporated in 1994 and is headquartered in Denver, Colorado.
 CEO
 WEBSITEwww.davita.com
 EMPLOYEES65535

DaVita Inc Frequently Asked Questions


What is the ticker symbol for DaVita Inc? What does DVA stand for in stocks?

DVA is the stock ticker symbol of DaVita Inc. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of DaVita Inc (DVA)?

As of Thu Dec 07 2023, market cap of DaVita Inc is 9.66 Billion. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of DVA stock?

You can check DVA's fair value in chart. The fair value of DaVita Inc is provided for various growth and macro-economic scenarios from very pessimiatic to very optimistic assumptions. These fair values are estimates from Grufity's Fair Value model based on company's past performance. However, past performance of DaVita Inc is no guarantee of future performance. These fairvalue estimates should only be used as one of the inputs in your stock analysis. We provide model's historical fair value estimates for DVA so that you know how good or bad the model has been in the past so you can discard it if needed. There are others that provide fair values of stocks such as wallmine, finbox, gurufocus and finviz. Most provide point in time estimates. We provide a history of our models fair value estimates so that you can get a sense of it's usefulness. Otherwise this data point is of little use.

Is DaVita Inc a good stock to buy?

The fair value guage provides a quick view whether DVA is over valued or under valued. Whether DaVita Inc is cheap or expensive depends on the assumptions which impact DaVita Inc's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for DVA.

What is DaVita Inc's Price to Earnings (PE) and Price to sales (PS) ratio?

As of Thu Dec 07 2023, DVA's PE ratio (Price to Earnings) is 15.86 and Price to Sales (PS) ratio is 0.81. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. DVA PE ratio will change depending on the future growth rate expectations of investors.

What is 5 year return on DaVita Inc's stock?

In the past 10 years, DaVita Inc has provided 0.054 (multiply by 100 for percentage) rate of return.